Israel Gp Ii, L.p. Orbimed — Insider Trading History & SEC Filings
SEC CIK 1682090 — Director, 10% Owner
Israel Gp Ii, L.p. Orbimed is a corporate insider tracked via SEC EDGAR filings. Officers, directors, and 10%+ beneficial owners must report transactions in their company's stock on Form 4, typically within two business days. This page shows Israel Gp Ii, L.p. Orbimed's reported transactions, current holdings across companies, and filing history.
Frequently asked questions
Who is Israel Gp Ii, L.p. Orbimed?
Israel Gp Ii, L.p. Orbimed is a corporate insider (SEC CIK 1682090) with reported roles including Director, 10% Owner. This page tracks their SEC Form 4, Form 3, and Form 5 filings, current holdings, and transaction history.
How current is this insider data?
Insiders must report transactions to the SEC typically within two business days. finshort ingests new EDGAR filings continuously, so transactions appear shortly after they are filed.